Viral Vaccines Market to be Worth $64.18 Billion by 2031 - Exclusive Report by Meticulous Research®
According to a new market research report, ' Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form (Liquid, ...
Taiwan News1d
Viral Vectors and Plasmid DNA Manufacturing Market Forecast Detailed Growth Trends and Predictions for 2033
The global viral vectors and plasmid DNA manufacturing market was valued at $918.37 million in 2019, and is estimated to reach at $4,978.54 million by 2027, registering a CAGR of ...
PharmiWeb8d
Viral Vector Development Market to Surge to USD 4.1 Billion by 2033, Growing at 18.7% CAGR
Viral Vector Development MarketThe Viral Vector Development Market is set for impressive growth, with its valuation expected to rise from USD 730.7 million in 2023 to USD 4.1 billion by 2033, ...
GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
Adds to Growing Portfolio of Intellectual Property AssetsATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a ...
GEN8d
Nanofiber-Based Cell Culture Systems for Viral Vector Production
Cellevate has launched its Cellevat3d nanofiber-based cell culture systems. They are designed to enable faster bioprocessing, more efficient scale up, and more viral vector yield. Cellevate asserts ...
Business Wire2d
First Subject Dosed in Initial Cohort of Phase 2b Clinical Study of CyanVac’s Intranasal COVID-19 Vaccine Candidate
CyanVac LLC, a clinical-stage biotechnology company developing intranasal vaccines using a transformational parainfluenza virus 5 (PIV5)-based vector, ...
GeoVax Labs receives Notice of Allowance for cancer vaccine patent
GeoVax Labs (GOVX) announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent Application No. 17/876,682 ...